Thyroid tablets recalled because they could be ‘superpotent,' lead to hyperthyroidism

Source NBC Local
Original Load Date Aug. 25, 2026, 1:01 p.m.
Last Updated Aug. 25, 2026, 1:01 p.m.
Original URL https://www.nbcchicago.com/news/local/superpotent-thyroid-medication-recalled-due-to-risk-of-hyperthyroidism-if-taken/3979998/

Article Preview

Drug company Vitruvias Therapeutics Inc. has issued a nationwide recall for thyroid tablets after it was found the medication could be "superpotent," meaning the pills -- meant to treat hypothyroidism -- could potentially lead to hyperthyroidism if taken. The voluntary recall applies to Lot 504950 ...